The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
amgen fremont | 570 |
pfizer | 274 |
amgen | 99 |
abgenix | 59 |
warner-lambert company | 40 |
pfizer products | 32 |
psma development company | 23 |
curagen corporation | 17 |
millennium pharmaceuticals | 12 |
celldex therapeutics | 10 |
amgen fremont | 34 |
pfizer | 18 |
amgen | 12 |
abgenix | 2 |
warner-lambert company | 2 |
millennium pharmaceuticals | 1 |
athletics merger sub | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
human monoclonal antibodies to activin receptor-like kinase-1 | 74 | 2005 |
antibodies to insulin-like growth factor i receptor | 64 | 2001 |
antibodies to opgl | 61 | 2001 |
antibodies to m-csf | 48 | 2003 |
antibodies directed to the deletion mutants of epidermal growth factor receptor and uses… 🛈 | 48 | 2003 |
antibodies to cd40 | 45 | 2001 |
human monoclonal antibodies to ctla-4 | 43 | 1998 |
antibodies to madcam | 37 | 2004 |
antibodies to ccr2 | 33 | 2008 |
specific binding agents to hepatocyte growth factor | 32 | 2003 |